Cantor Fitzgerald upgrades Madrigal Pharmaceuticals stock on strong Rezdiffra sales
PositiveFinancial Markets

Cantor Fitzgerald has upgraded Madrigal Pharmaceuticals' stock, citing strong sales of its drug Rezdiffra. This positive development reflects confidence in the company's growth and market performance.
— Curated by the World Pulse Now AI Editorial System





